These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2128079)

  • 21. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.
    Stott DJ; Saniabadi AR; Hosie J; Lowe GD; Ball SG
    Eur J Clin Pharmacol; 1988; 35(2):123-9. PubMed ID: 3142775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens.
    Devaud LL; Hollingsworth EB
    Eur J Pharmacol; 1991 Jan; 192(3):427-9. PubMed ID: 1675992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the serotonin-uptake inhibitor, fluoxetine, on immunoreactive serotonin innervation in the rat pituitary gland.
    Saland LC; Wallace JA; Reyes E; Samora A; Maez D; Comunas F
    Brain Res Bull; 1987 Aug; 19(2):261-7. PubMed ID: 2444314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind placebo-controlled investigation of the psychomotor profile of clopidogrel in healthy volunteers.
    Adam JK; Rmaih WN
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):507-9. PubMed ID: 19034035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G; Pozzi F; Marini S; Grispini A; Pasini A; Ciani N
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists.
    Wong DT; Reid LR; Threlkeld PG
    Pharmacol Biochem Behav; 1988 Oct; 31(2):475-9. PubMed ID: 3266670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Information processing in anxiety: a pilot study of the effect of manipulating 5-HT function.
    Andrews TM; Anderson IM
    J Psychopharmacol; 1998; 12(2):155-60. PubMed ID: 9694028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
    Kaur G; Kulkarni SK
    Brain Res; 2002 Jul; 943(2):206-15. PubMed ID: 12101043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The psychomotor and cognitive effects of litoxetine in young and middle aged volunteers.
    Fairweather DB; Patat A; Rosenzweig P; Curson VH; Dunmore C; Dubruc C; Hindmarch I
    Br J Clin Pharmacol; 1995 Aug; 40(2):119-25. PubMed ID: 8562293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.
    Welsh SE; Romano AG; Harvey JA
    Psychopharmacology (Berl); 1998 May; 137(2):157-63. PubMed ID: 9630002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
    Geyer MA; Tapson GS
    Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
    Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ
    Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
    Den Boer JA; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):85-94. PubMed ID: 1697419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors.
    Parga J; Rodriguez-Pallares J; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Dev Neurobiol; 2007 Jan; 67(1):10-22. PubMed ID: 17443768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM; Marini S; Gregori S
    Int J Clin Pharmacol Res; 1987; 7(2):111-9. PubMed ID: 3108171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B; Ursin R
    Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers.
    Altamura AC; Colacurcio F; Marini S
    Int J Clin Pharmacol Res; 1989; 9(3):197-201. PubMed ID: 2568349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.